<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00636363</url>
  </required_header>
  <id_info>
    <org_study_id>554</org_study_id>
    <nct_id>NCT00636363</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of a Bausch &amp; Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To the safety and efficacy of a Bausch &amp; Lomb Multipurpose Solution when compared to Ciba
      vision Aquify Multipurpose solution
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Slit-lamp Findings &gt; Grade 2</measure>
    <time_frame>Over 4 visits for 3 month period</time_frame>
    <description>eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Responses to Comfort Related Symptoms/Complaints</measure>
    <time_frame>Over 4 visits for the 3 month period</time_frame>
    <description>Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contact Lens Deposits</measure>
    <time_frame>At each visit for 3 months</time_frame>
    <description>Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">541</enrollment>
  <condition>Contact Lens Solutions</condition>
  <arm_group>
    <arm_group_label>Multipurpose Solution - Rub Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multipurpose Solution - No Rub Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ciba Vision Aquify Multipurpose Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bausch &amp; Lomb Multipurpose Solution - Rub Care</intervention_name>
    <description>Daily care for contact lenses - rub care regimen</description>
    <arm_group_label>Multipurpose Solution - Rub Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bausch &amp; Lomb Multipurpose Solution - No Rub Care</intervention_name>
    <description>Daily care for contact lenses - no rub care regimen</description>
    <arm_group_label>Multipurpose Solution - No Rub Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ciba Vision Aquify Multipurpose Solution</intervention_name>
    <description>daily care for contact lenses</description>
    <arm_group_label>Ciba Vision Aquify Multipurpose Solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subject is a habitual wearer of a silicone hydrogel or group IV contact lens

          -  VA correctable to 0.3 LogMar or better (driving vision)

          -  Clear central cornea

          -  Subject uses a lens care system on a regular basis

        Exclusion Criteria:

          -  Systemic disease affecting ocular health

          -  Using systemic or topical medications

          -  wear monovision, multifocal or toric contact lenses

          -  Any grade 2 or greater slit lamp findings
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohinder Merchea, OD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Place Eye Care</name>
      <address>
        <city>LeRoy</city>
        <state>New York</state>
        <zip>14482</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2008</study_first_submitted>
  <study_first_submitted_qc>March 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2008</study_first_posted>
  <results_first_submitted>February 3, 2011</results_first_submitted>
  <results_first_submitted_qc>March 11, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 8, 2011</results_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>541 participants were enrolled in this 3 month study (1152 eyes). First participant was enrolled Mar 7, 2008 and last participant exited Aug 1, 2008. Participant were enrolled from 24 investigative sites in the US.</recruitment_details>
      <pre_assignment_details>Of the 541 participants enrolled 6 were ineligible at baseline. These subjects met the exclusion criteria. 535 participants participated in the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Multipurpose Solution - Rub Care</title>
          <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="P2">
          <title>Multipurpose Solution - No Rub Care</title>
          <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="P3">
          <title>Ciba Vision Aquify Multipurpose Solution</title>
          <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="178"/>
                <participants group_id="P2" count="176"/>
                <participants group_id="P3" count="181"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="165"/>
                <participants group_id="P2" count="156"/>
                <participants group_id="P3" count="163"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Conjunctivitis</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Positive slit lamp finding</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study related symptoms/complaints</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Met ineligibility criteria</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missed &gt; 1 visit</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of motivation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Multipurpose Solution - Rub Care</title>
          <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="B2">
          <title>Multipurpose Solution - No Rub Care</title>
          <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="B3">
          <title>Ciba Vision Aquify Multipurpose Solution</title>
          <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="178"/>
            <count group_id="B2" value="176"/>
            <count group_id="B3" value="181"/>
            <count group_id="B4" value="535"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18-66 years of age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                    <measurement group_id="B2" value="176"/>
                    <measurement group_id="B3" value="181"/>
                    <measurement group_id="B4" value="535"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="126"/>
                    <measurement group_id="B4" value="383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="55"/>
                    <measurement group_id="B4" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="168"/>
                    <measurement group_id="B2" value="172"/>
                    <measurement group_id="B3" value="174"/>
                    <measurement group_id="B4" value="514"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178"/>
                    <measurement group_id="B2" value="176"/>
                    <measurement group_id="B3" value="181"/>
                    <measurement group_id="B4" value="535"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Slit-lamp Findings &gt; Grade 2</title>
        <description>eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.</description>
        <time_frame>Over 4 visits for 3 month period</time_frame>
        <population>Over all follow-up visits, all dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Multipurpose Solution - Rub Care</title>
            <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
          </group>
          <group group_id="O2">
            <title>Multipurpose Solution - No Rub Care</title>
            <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
          </group>
          <group group_id="O3">
            <title>Ciba Vision Aquify Multipurpose Solution</title>
            <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
          </group>
        </group_list>
        <measure>
          <title>Slit-lamp Findings &gt; Grade 2</title>
          <description>eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.</description>
          <population>Over all follow-up visits, all dispensed eyes</population>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="177"/>
                <count group_id="O2" value="176"/>
                <count group_id="O3" value="179"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="354"/>
                <count group_id="O2" value="352"/>
                <count group_id="O3" value="358"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Responses to Comfort Related Symptoms/Complaints</title>
        <description>Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
        <time_frame>Over 4 visits for the 3 month period</time_frame>
        <population>Comfort related symptoms/complaints for all eligible, dispensed eyes. Over all follow-up visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Multipurpose Solution - Rub Care</title>
            <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
          </group>
          <group group_id="O2">
            <title>Multipurpose Solution - No Rub Care</title>
            <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
          </group>
          <group group_id="O3">
            <title>Ciba Vision Aquify Multipurpose Solution</title>
            <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Responses to Comfort Related Symptoms/Complaints</title>
          <description>Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
          <population>Comfort related symptoms/complaints for all eligible, dispensed eyes. Over all follow-up visits.</population>
          <units>Scores on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="172"/>
                <count group_id="O3" value="176"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="352"/>
                <count group_id="O2" value="344"/>
                <count group_id="O3" value="352"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="12.9"/>
                    <measurement group_id="O2" value="84.6" spread="16.5"/>
                    <measurement group_id="O3" value="86.9" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of day comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.2" spread="17.6"/>
                    <measurement group_id="O2" value="77.1" spread="20.8"/>
                    <measurement group_id="O3" value="79.1" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Burning/stinging upon inserstion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.1" spread="13.5"/>
                    <measurement group_id="O2" value="89.1" spread="15.8"/>
                    <measurement group_id="O3" value="90.1" spread="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="15.3"/>
                    <measurement group_id="O2" value="85.0" spread="17.4"/>
                    <measurement group_id="O3" value="86.8" spread="15.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.6" spread="12.7"/>
                    <measurement group_id="O2" value="90.9" spread="12.9"/>
                    <measurement group_id="O3" value="90.8" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.2" spread="14.0"/>
                    <measurement group_id="O2" value="83.0" spread="19.0"/>
                    <measurement group_id="O3" value="83.7" spread="16.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.4" spread="13.2"/>
                    <measurement group_id="O2" value="91.0" spread="13.1"/>
                    <measurement group_id="O3" value="91.2" spread="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9" spread="10.9"/>
                    <measurement group_id="O2" value="88.9" spread="16.2"/>
                    <measurement group_id="O3" value="92.6" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens cleanliness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.2" spread="11.7"/>
                    <measurement group_id="O2" value="89.2" spread="15.3"/>
                    <measurement group_id="O3" value="91.8" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens Handling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.1" spread="9.0"/>
                    <measurement group_id="O2" value="95.1" spread="7.2"/>
                    <measurement group_id="O3" value="94.9" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Contact Lens Deposits</title>
        <description>Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.</description>
        <time_frame>At each visit for 3 months</time_frame>
        <population>Lens deposits, All eligible, dispensed eyes.</population>
        <group_list>
          <group group_id="O1">
            <title>Multipurpose Solution - Rub Care</title>
            <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
          </group>
          <group group_id="O2">
            <title>Multipurpose Solution - No Rub Care</title>
            <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
          </group>
          <group group_id="O3">
            <title>Ciba Vision Aquify Multipurpose Solution</title>
            <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
          </group>
        </group_list>
        <measure>
          <title>Contact Lens Deposits</title>
          <description>Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.</description>
          <population>Lens deposits, All eligible, dispensed eyes.</population>
          <units>Eyes</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="175"/>
                <count group_id="O2" value="169"/>
                <count group_id="O3" value="175"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="350"/>
                <count group_id="O2" value="338"/>
                <count group_id="O3" value="350"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Light</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="147"/>
                    <measurement group_id="O2" value="176"/>
                    <measurement group_id="O3" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Medium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                    <measurement group_id="O2" value="84"/>
                    <measurement group_id="O3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heavy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 Months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Multipurpose Solution - Rub Care</title>
          <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="E2">
          <title>Multipurpose Solution - No Rub Care</title>
          <description>Bausch &amp; Lomb Multipurpose Solution for use with contact lens care</description>
        </group>
        <group group_id="E3">
          <title>Ciba Vision Aquify Multipurpose Solution</title>
          <description>Ciba Vision Aquify Multipurpose Solution for use with contact lens care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Steffen</name_or_title>
      <organization>Bausch &amp; Lomb</organization>
      <phone>(585) 338-6399</phone>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

